Antihypertensive drugs and risk of COVID-19?
Lancet Respir Med
.
2020 May;8(5):e28.
doi: 10.1016/S2213-2600(20)30158-2.
Epub 2020 Mar 26.
Author
Joshua D Brown
1
Affiliation
1
Center for Drug Evaluation & Safety, Department of Pharmaceutical Outcomes and Policy, University of Florida College of Pharmacy, Gainesville, FL 32606, USA. Electronic address: joshua.brown@ufl.edu.
PMID:
32222168
PMCID:
PMC7194728
DOI:
10.1016/S2213-2600(20)30158-2
No abstract available
Publication types
Letter
Comment
MeSH terms
Antihypertensive Agents
Betacoronavirus
COVID-19
Coronavirus Infections
Diabetes Mellitus*
Humans
Hypertension*
Pandemics
Pneumonia, Viral
SARS-CoV-2
Substances
Antihypertensive Agents
Grants and funding
P30 AG028740/AG/NIA NIH HHS/United States